FDA Inspection 1244904 — Grifols Canada Plasma II Inc.
The FDA completed an inspection of Grifols Canada Plasma II Inc. on Jul 16, 2024 in Winnipeg. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 16, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Winnipeg (Canada)